Home
Pharma
HealthTech
Physicians
Technology
Clinical
Patientcare
PMDA
Search
Friday, February 15, 2019
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
news
Home
Pharma
HealthTech
Physicians
Technology
Clinical
Patientcare
PMDA
Home
PMDA
PMDA
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
PMDA
Revisions of PRECAUTIONS:Aripiprazole, etc. posted
akthealth
-
January 11, 2018
PMDA
“PMDA Medical Safety Information No.52” Posted
PMDA
Revisions of PRECAUTIONS: Medical Devices Containing Chlorhexidine Gluconate or Chlorhexidine Hydrochloride posted
PMDA
[PMDA]Annual Report FY 2016 posted
PMDA
PRECAUTIONS in the Package Insert of Medical Devices Containing Chlorhexidine Gluconate or Chlorhexidine Hydrochloride posted
PMDA
“PMDA Medical Safety Information No.50” Posted
akthealth
-
March 27, 2017
0
PMDA
PMDA Alert for Proper Use of Drugs: No.11
akthealth
-
March 21, 2017
0
PMDA
Revisions of PRECAUTIONS: Lamotrigine, etc. posted
akthealth
-
March 21, 2017
0
PMDA
Revised “PMDA Medical Safety Information No.33” Posted
akthealth
-
March 6, 2017
0
PMDA
Points to Consider regarding the Notification and Publication of Package Insert...
akthealth
-
February 21, 2017
590
PMDA
Revisions of PRECAUTIONS: Hydroxyzine Hydrochloride, etc. posted
akthealth
-
February 21, 2017
87
PMDA
[PMDA]“Rational Medicine” Initiative posted
akthealth
-
February 21, 2017
135
1
2
Page 2 of 2
MOST POPULAR
UK firms link to develop ADCs for cancer
September 20, 2017
EC approves for Merck’s Keytruda for bladder cancer indication
September 6, 2017
Sir Mike Richards joins Incisive Health
September 20, 2017
CR UK, Newcastle Uni extend alliance with Astex
August 17, 2017
Load more
HOT NEWS
Clinical
FDA Committee Votes Down Janssen’s Plivensia Arthritis Drug
Pharma
Cancer Drugs Fund poor value for money, study finds
Pharma
Lilly reports positive data for breast cancer drug
Pharma
NICE refuses to expand use of Roche’s IPF drug Esbriet
